Sunshine Earth Labs Ltd. announced it has entered into a supply agreement with Optimi Health Corp. Under terms of the agreement, Optimi will supply GMP quality-controlled Full Spectrum Active Pharmaceutical Ingredient (API) and encapsulated psilocybin product, and encapsulated MDMA from Optimi's 10,000 sq ft, facility in Princeton, British Columbia. Both companies are licensed by Health Canada and dedicated to maintaining the high level of GMP drug production, as mandated by Health Canada under the Controlled Drugs and Substances Act and Part C, Division 2 of the Food and Drug Regulations.